Skip to main content
SpringerLink
Log in

DPP-4 inhibitors do not increase risk of serious muscular disorders

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Pariente A, et al. DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus. Drug Safety : 18 Apr 2020. Available from: URL: https://doi.org/10.1007/s40264-020-00936-1

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

DPP-4 inhibitors do not increase risk of serious muscular disorders. Reactions Weekly 1801, 7 (2020). https://doi.org/10.1007/s40278-020-77667-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-77667-z

Search

Navigation